AstraZeneca (AZN)

Add to Watchlists Create an Alert
73.18 -0.46  -0.62% NYSE Sep 17, 3:34PM BATS Real time Currency in USD

AstraZeneca Cash from Investing (Quarterly):

-1.178B for June 30, 2014

View 4,000+ financial data types

View Full Chart

AstraZeneca Cash from Investing (Quarterly) Chart

Export Data
Save Image

AstraZeneca Historical Cash from Investing (Quarterly) Data

View and export this data going back to 2000. Start your YCharts Lite Membership
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
June 30, 2014 -1.178B
March 31, 2014 -3.777B
Dec. 31, 2013 -1.004B
Sept. 30, 2013 -647.00M
June 30, 2013 -874.00M
March 31, 2013 -364.00M
Dec. 31, 2012 -514.00M
Sept. 30, 2012 -2.698B
June 30, 2012 760.00M
March 31, 2012 593.00M
Dec. 31, 2011 -3.58B
Sept. 30, 2011 1.272B
June 30, 2011 186.00M
March 31, 2011 100.00M
Dec. 31, 2010 -452.00M
Sept. 30, 2010 258.00M
June 30, 2010 -925.00M
March 31, 2010 -1.107B
Dec. 31, 2009 -1.904B
Sept. 30, 2009 -410.00M
June 30, 2009 -236.00M
March 31, 2009 74.00M
Dec. 31, 2008 -472.00M
Sept. 30, 2008 -225.00M
June 30, 2008 -262.00M
   
March 31, 2008 -2.937B
Dec. 31, 2007 -427.00M
Sept. 30, 2007 33.00M
June 30, 2007 -13.88B
March 31, 2007 -616.00M
Dec. 31, 2006 285.00M
Sept. 30, 2006 -546.00M
June 30, 2006 1.892B
March 31, 2006 -1.903B
Dec. 31, 2005 -561.00M
Sept. 30, 2005 -1.098B
June 30, 2005 506.00M
March 31, 2005 -29.00M
Dec. 31, 2004 1.664B
Sept. 30, 2004 -616.00M
June 30, 2004 218.00M
March 31, 2004 -296.00M
Dec. 31, 2003 70.00M
Sept. 30, 2003 -329.00M
June 30, 2003 -263.00M
March 31, 2003 -330.00M
Dec. 31, 2002 -509.00M
Sept. 30, 2002 -401.00M
June 30, 2002 -348.00M
March 31, 2002 -285.00M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Get data for
Advertisement

AZN Cash from Investing (Quarterly) Benchmarks

Companies
Bristol-Myers Squibb -1.511B
GlaxoSmithKline -260.32M
Eli Lilly -468.90M

AZN Cash from Investing (Quarterly) Range, Past 5 Years

Minimum -3.777B Mar 2014
Maximum 1.272B Sep 2011
Average -813.25M

AZN Cash from Investing (Quarterly) Excel Add-In Codes

  • Metric Code: cash_investing
  • Latest data point: =YCP("AZN", "cash_investing")
  • Last 5 data points: =YCS("AZN", "cash_investing", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.